drugset
Drugs / Gelatin Tannate
last change Jun 2020 re-read 2 minutes ago

Gelatin Tannate

also known as gelatine tannate

Other / unclassified

Developed for
diarrheal disease · gastroenteritis
Investigated by
Axonal-Biostatem · Ferrer Internacional S.A.

Trials 1 · a red edge is where a trial was stopped

today NCT04065529 · Ph 3
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04065529 Sep 2019 → Jun 2020 diarrheal disease Ferrer Internacional S.A. Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02280759 Comparator Nov 2014 → Jun 2017 gastroenteritis Medical University of Warsaw Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Gelatin Tannate ClinicalTrials.gov intervention name — accepted as the source's own label NCT02280759 ↗
1

NCT04065529 ↗
Known as gelatine tannate “OBJECTIVE: To assess the efficacy of gelatine tannate (a complex of tannic acid with astringent and anti-inflammatory properties, and a protective gelatine) for the treatment...” PMID 29794092 ↗ May 2018
Modality Other / unclassified “Gelatine tannate is a complex of tannic acid, which possesses astringent and anti-inflammatory properties, and a protective gelatine.” PMID 26895988 ↗ Feb 2016